Article Versions Notes

Wee EG-T, Kempster S, Ferguson D, Hall J, Ham C, Morris S, Crook A, Gilbert SC, Korber B, Almond N, et al. Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine. Vaccines. 2024; 12(9):965. https://doi.org/10.3390/vaccines12090965

Wee, Edmund G.-T., Sarah Kempster, Deborah Ferguson, Joanna Hall, Claire Ham, Susan Morris, Alison Crook, Sarah C. Gilbert, Bette Korber, Neil Almond, and et al. 2024. "Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine" Vaccines 12, no. 9: 965. https://doi.org/10.3390/vaccines12090965

Wee, E. G.-T., Kempster, S., Ferguson, D., Hall, J., Ham, C., Morris, S., Crook, A., Gilbert, S. C., Korber, B., Almond, N., & Hanke, T. (2024). Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine. Vaccines, 12(9), 965. https://doi.org/10.3390/vaccines12090965